BIOLARGO, INC. [FORM OF] WARRANT TO PURCHASE COMMON STOCK WITH CALL PROVISIONBiolargo, Inc. • August 15th, 2014 • Chemicals & allied products • Delaware
THIS CERTIFIES THAT, for value received, ___________________________ (the “Holder”), is entitled upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date issued set forth above (the “Initial Exercise Date”) and on or prior to the close of business on July 31, 2019 (the “Termination Date”) but not thereafter, to subscribe for and purchase from BioLargo, Inc., a Delaware corporation (the “Company”), up to ________ shares (the “Warrant Shares”) of common stock, par value, $0.00067, of the Company (the “Common Stock”).
LICENSE AGREEMENTLicense Agreement • August 15th, 2014 • Biolargo, Inc. • Chemicals & allied products
This License Agreement (the “Agreement”) is made this 8th day of August, 2014 (the “Execution Date”) but is effective as of February 1, 2014, 2014 (the “Effective Date”), by and between Peter Holdings Pty Ltd, an Australian corporation (“Peter Holdings”), BioLargo, Inc., a Delaware corporation, having a principal place of business at 3500 W. Garry Ave., Santa Ana, California, (“BioLargo”), and InsulTech Manufacturing, LLC, an Arizona limited liability company d/b/a Clarion Water, having a principal place of business at 3530 W. Garry Ave., Santa Ana, California (“Licensee”). BioLargo and Peter Holdings are referred to herein collectively as “Licensor”, and Licensee and Licensor are referred to herein individually as a “Party” and collectively as the “Parties”.
